| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology, The Medical School, University of Birmingham, Birmingham B15 2TT, UK
It is accepted that NO plays a role in hypoxic vasodilatation in several tissues. For rat hindlimb muscle there is evidence that during systemic hypoxia endogenously released adenosine acts on endothelial A1 receptors to evoke dilatation in a NO-dependent fashion, implying requirement for, or mediation by, NO. We tested in vivo whether systemic hypoxia and adenosine release NO from muscle. In anaesthetized rats, arterial blood pressure (ABP) and femoral blood flow (FBF) were recorded allowing computation of femoral vascular conductance (FVC). Blood samples taken from femoral artery and vein allowed electrochemical measurement of plasma [NO] after reduction of NO3– and NO2–. Systemic hypoxia and adenosine infusion for 5 min each, evoked an increase in FVC that was attenuated by the NO synthase (NOS) inhibitor L-NAME (Group 1, n = 8) and adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, Group 2, n = 6). Concomitant systemic hypoxia and adenosine infusion evoked increases in venous–arterial [NO] difference ([NO]v-a) from –1.4 ± 0.85 to 6.6 ± 1.6 and 2.3 ± 0.78 to 8.4 ± 1.8 nmol l–1, respectively (mean ± S.E.M), which were abolished by L-NAME (–0.72 ± 0.90 to –0.87 ± 0.74 and 0.72 ± 0.85 to –0.97 ± 1.1 nmol l–1, respectively). DPCPX also abolished the hypoxia-evoked increase in [NO]v-a (control –4.2 ± 1.8 to 12.5 ± 3.7 nmol l–1, with DPCPX –0.63 ± 2.6 to 3.3 ± 2.9 nmol l–1) and decreased the adenosine-evoked increase in [NO]v-a (control 1.1 ± 1.5 to 24 ± 14, with DPCPX –0.43 ± 2.9 to 12 ± 5.9 nmol l–1). These results allow the novel conclusion that the muscle vasodilatation of systemic hypoxia is partly mediated by adenosine acting at endothelial A1 receptors to stimulate synthesis and release of NO, which then induces dilatation.
(Received 18 July 2005;
accepted after revision 22 August 2005;
first published online 25 August 2005)
Corresponding author C. J. Ray: Department of Physiology, The Medical School, University of Birmingham, Birmingham B15 2TT, UK. Email: c.j.ray{at}bham.ac.uk
This article has been cited by other articles:
|
|
 |
|
  J. M. Marshall The roles of adenosine and related substances in exercise hyperaemia J. Physiol., September 15, 2007; 583(3): 835 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Winter and K. A. Dora Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries J. Physiol., July 1, 2007; 582(1): 335 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cappello, T. Angelone, B. Tota, P. Pagliaro, C. Penna, R. Rastaldo, A. Corti, G. Losano, and M. C. Cerra Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H719 - H727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Clanton Hypoxia-induced reactive oxygen species formation in skeletal muscle J Appl Physiol, June 1, 2007; 102(6): 2379 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Walsh and J. M. Marshall The early effects of chronic hypoxia on the cardiovascular system in the rat: role of nitric oxide J. Physiol., August 15, 2006; 575(1): 263 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Walsh and J. M. Marshall The role of adenosine in the early respiratory and cardiovascular changes evoked by chronic hypoxia in the rat J. Physiol., August 15, 2006; 575(1): 277 - 289. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
